Download FREE Sample
Table of Contents
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Market Forecasting
- Executive Summary
- Market Overview
- Market Dynamics
- Drivers and opportunities
- Restraints and challenges
- Market Dynamics
- Global Cell-based Assays Market - Size & Forecast (2022-2029), By Product Type
- Instruments/equipment
- Consumables
- Assay kits and reagents
- Cell lines
- Other consumables (microplates, probes and labels etc.)
- Global Cell-based Assays Market - Size & Forecast (2022-2029), By Application
- Drug discovery/development
- Biomedical research (basic research, cancer research, stem cell research, neuroscience)
- Clinical diagnostics
- Others
- Global Cell-based Assays Market - Size & Forecast (2022-2029), By End User
- Pharma/biotech companies
- Healthcare facilities
- Academic & research institutes
- Others
- Global Cell-based Assays Market - Size & Forecast (2022-2029), By Region
- North America (U.S. & Canada)
- Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
- Asia Pacific (China, India, Japan, Rest of Asia Pacific)
- Rest of the World (Latin America, Middle East & Africa)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Competitive Positioning of Key Players (2023)
- Key Strategies Assessment, By Player (2021-2023)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Other Developments
- Key Players and their Competitive Positioning
- Key Companies Scanned (Indicative List)
- BD Biosciences
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer
- Corning Inc.
- Charles River Laboratories
- Danaher Corporation
- Hoffmann-La Roche Ltd.
- Lonza
- Merck KGaA
- Promega Corporation
- Other Players
